Fred Alger Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,182
Closed -$223K 460
2026
Q1
$223K Sell
1,182
-624
-35% -$109K ﹤0.01% 417
2025
Q4
$307K Sell
1,806
-387
-18% -$59.3K ﹤0.01% 428
2025
Q3
$289K Sell
2,193
-64
-3% -$7.68K ﹤0.01% 423
2025
Q2
$240K Buy
2,257
+410
+22% +$44.5K ﹤0.01% 426
2025
Q1
$229K Buy
+1,847
New +$241K ﹤0.01% 411
2022
Q4
Sell
-17,746
Closed -$2.37M 542
2022
Q3
$2.37M Sell
17,746
-88,770
-83% -$13.5M 0.01% 328
2022
Q2
$16.6M Buy
106,516
+84,786
+390% +$13.1M 0.08% 180
2022
Q1
$3.38M Buy
+21,730
New +$3.15M 0.01% 305
2018
Q3
Sell
-6,000
Closed -$1.03M 562
2018
Q2
$1.03M Buy
+6,000
New +$981K ﹤0.01% 323
2016
Q4
Sell
-21
Closed -$3K 503
2016
Q3
$3K Sell
21
-7,397
-100% -$997K ﹤0.01% 485
2016
Q2
$1.05M Sell
7,418
-104
-1% -$15.3K 0.01% 322
2016
Q1
$982K Sell
7,522
-1,712
-19% -$213K 0.01% 377
2015
Q4
$1.3M Sell
9,234
-2,999
-25% -$416K 0.01% 363
2015
Q3
$1.63M Sell
12,233
-32,488
-73% -$5.59M 0.01% 359
2015
Q2
$7.87M Sell
44,721
-70,450
-61% -$12.7M 0.04% 253
2015
Q1
$19.9M Sell
115,171
-22,135
-16% -$3.8M 0.09% 167
2014
Q4
$22.5M Sell
137,306
-14,017
-9% -$2.33M 0.11% 168
2014
Q3
$24.3M Sell
151,323
-8,646
-5% -$1.33M 0.12% 152
2014
Q2
$23.5M Buy
159,969
+8,785
+6% +$1.22M 0.12% 167
2014
Q1
$21M Buy
+151,184
New +$22.8M 0.1% 199

Other funds holding JAZZ

Fred Alger Management's JAZZ Position: Q2 2026 in Review

Fred Alger Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 1,182 shares — an estimated $223K sold.

Fred Alger Management first reported a position in JAZZ in Q1 2014 and held it in 20 quarters. The position peaked at $24.3M in Q3 2014. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Fred Alger Management reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Fred Alger Management sold 1,182 Jazz Pharmaceuticals shares in Q2 2026, an estimated $223K.
  • Fred Alger Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 20 quarters.
  • Fred Alger Management's Jazz Pharmaceuticals position peaked at $24.3M in Q3 2014.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.